Keith R. Edwards

7.2k total citations
101 papers, 2.9k citations indexed

About

Keith R. Edwards is a scholar working on Pathology and Forensic Medicine, Ecology and Plant Science. According to data from OpenAlex, Keith R. Edwards has authored 101 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 31 papers in Ecology and 22 papers in Plant Science. Recurrent topics in Keith R. Edwards's work include Multiple Sclerosis Research Studies (26 papers), Peatlands and Wetlands Ecology (24 papers) and Coastal wetland ecosystem dynamics (18 papers). Keith R. Edwards is often cited by papers focused on Multiple Sclerosis Research Studies (26 papers), Peatlands and Wetlands Ecology (24 papers) and Coastal wetland ecosystem dynamics (18 papers). Keith R. Edwards collaborates with scholars based in United States, Czechia and Spain. Keith R. Edwards's co-authors include C. Edward Proffitt, Hana Šantrůčková, Steven E. Travis, Susan B. Filskov, Janis M. Peyser, Charles M. Poser, Tomáš Picek, Eva Kaštovská, Andrew Goodman and Hana Čı́žková and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Ecology.

In The Last Decade

Keith R. Edwards

97 papers receiving 2.8k citations

Peers

Countries citing papers authored by Keith R. Edwards

Since Specialization

Citations

This map shows the geographic impact of Keith R. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith R. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith R. Edwards more than expected).

Fields of papers citing papers by Keith R. Edwards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith R. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith R. Edwards. The network helps show where Keith R. Edwards may publish in the future.

Co-authorship network of co-authors of Keith R. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Keith R. Edwards. A scholar is included among the top collaborators of Keith R. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith R. Edwards. Keith R. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple environmental factors interact to affect wet grassland ecosystem functions 2025 ·Ecological Engineering ·Keith R. Edwards, Eva Kaštovská, Jiří Bárta, Tomáš Picek, Hana Šantrůčková	1
2	Environmental Effects on Assimilated Carbon Quantity and Quality in Two Different Wet Grassland Plants 2024 ·Wetlands ·(unknown), (unknown), Tomáš Picek, Keith R. Edwards	1
3	Multiple environmental factors, but not nutrient addition, directly affect wet grassland soil microbial community structure: a mesocosm study 2023 ·FEMS Microbiology Ecology ·Keith R. Edwards, Jiří Bárta, (unknown), Tomáš Picek	8
4	COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections 2022 ·Vaccines ·Dejan Jakimovski, (unknown), (unknown), Katelyn Kavak, (unknown), David Hojnacki, Channa Kolb, (unknown), Svetlana Eckert, (unknown), (unknown), Keith R. Edwards, Bianca Weinstock‐Guttman	15
5	COVID-19 mRNA vaccination leading to CNS inflammation: a case series 2021 ·Journal of Neurology ·Mahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz, Daniel M. Harrison, Shahamat Tauhid, (unknown), Maria K. Houtchens, Keith R. Edwards, Rohit Bakshi	98
6	Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis 2020 ·BMC Neurology ·Giancarlo Comi, Mark S. Freedman, José Meca-Lallana, Patrick Vermersch, Byoung Joon Kim, (unknown), Keith R. Edwards, Ralf Gold, Houari Korideck, (unknown), Elizabeth M. Poole, Patricia K. Coyle	2
7	Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? 2018 ·Neurology and Therapy ·(unknown), (unknown), (unknown), (unknown), Lisa Farnett, Keith R. Edwards	3
8	Additional Efficacy Analyses from the Phase 2b SYNERGY Study Investigating the Anti-LINGO-1 Monoclonal Antibody Opicinumab for Treatment of Disabling Multiple Sclerosis (P5.337) 2017 ·Neurology ·Michelle Mellion, Keith R. Edwards, Raymond Hupperts, Jelena Drulović, Xavier Montalbán, Hans‐Peter Hartung, Bruno Brochet, Peter A. Calabresi, Richard A. Rudick, (unknown), Yiwei Zhang, Diego Cadavid, Lei Xu	1
9	Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study 2017 ·Multiple Sclerosis and Related Disorders ·Patricia K. Coyle, Bhupendra Khatri, Keith R. Edwards, José Meca-Lallana, (unknown), (unknown), Myriam Bénamor, Sandrine Brette, Miqun Robinson, Ralf Gold	32
10	Case report: Leukocytoclastic vasculitis in an MS patient following alemtuzumab treatment (P5.403) 2017 ·Neurology ·(unknown), Keith R. Edwards, Cecilia Lezcano, (unknown), (unknown), (unknown)	5
11	BIIB033, Anti-LINGO-1 Antibody, for Treatment of Relapsing Forms of Multiple Sclerosis: Baseline Data of the Phase 2 SYNERGY Trial (P7.204) 2015 ·Neurology ·Diego Cadavid, Keith R. Edwards, Raymond Hupperts, Jelena Drulović, Krzysztof Selmaj, Robert T. Naismith, Luigi Maria Edoardo Grimaldi, Alexey Boiko, Óscar Fernández, Eli Silber, Howard Rossman, (unknown), Yi Chai, Lei Xu	4
12	Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hocanalyses of the EPOC trial 2014 ·BMC Neurology ·Jonathan Calkwood, Bruce Cree, Heidi Crayton, Daniel Kantor, Brian Steingo, Luigi Barbato, (unknown), Neetu Agashivala, (unknown), Nadia Tenenbaum, Keith R. Edwards	32
13	Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis 2014 ·Multiple Sclerosis and Related Disorders ·Edward Fox, Keith R. Edwards, (unknown), Daniel Wynn, (unknown), Heidi Crayton, Samuel F. Hunter, Cynthia Huffman, Edward Kim, Linda Pestreich, (unknown), Luigi Barbato	66
14	Direct effect of fertilization on microbial carbon transformation in grassland soils in dependence on the substrate quality 2010 ·Journal of Plant Nutrition and Soil Science ·Eva Kaštovská, Hana Šantrůčková, Tomáš Picek, (unknown), Keith R. Edwards	12
15	A phase 3 trial of extended release oral dalfampridine in multiple sclerosis 2010 ·Annals of Neurology ·Andrew Goodman, Theodore R. Brown, Keith R. Edwards, Lauren Krupp, Randall T. Schapiro, Ron Cohen, Lawrence N. Marinucci, Andrew R. Blight, (unknown)	246
16	Topiramate in Essential Tremor 2008 ·Clinical Neuropharmacology ·Gregory S. Connor, Keith R. Edwards, Daniel Tarsy	42
17	Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study 2007 ·Dementia and Geriatric Cognitive Disorders ·Keith R. Edwards, Donald R. Royall, Linda A. Hershey, David Lichter, Ann Marie Hake, Martin R. Farlow, Florence Pasquier, Stewart D. Johnson	64
18	Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis 2007 ·International Journal of Geriatric Psychiatry ·(unknown), Elise Rowan, Keith R. Edwards, Ian G. McKeith	30
19	Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 12-Week Interim Analysis 2003 ·Dementia and Geriatric Cognitive Disorders ·Keith R. Edwards, Linda A. Hershey, Laura O. Wray, Edward M. Bednarczyk, David Lichter, Martin R. Farlow, Stewart D. Johnson	44
20	Topiramate in the Preventive Treatment of Episodic Migraine: A Combined Analysis From Pilot, Double-Blind, Placebo-Controlled Trials 2003 ·CNS Spectrums ·Keith R. Edwards, (unknown), Shu‐Chen Wu, Marc Kamin, Joseph Hulihan	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact